Examining memory reconsolidation as a mechanism of nitrous oxide's antidepressant action.
Williams E. et al, (2025), Neuropsychopharmacology
Direct serotonin release in humans shapes aversive learning and inhibition.
Colwell MJ. et al, (2024), Nat Commun, 15
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial.
de Cates AN. et al, (2024), Br J Psychiatry, 1 - 8
Social dance and movement for mental health: A narrative review
Delattre B. et al, (2024), Mental Health Science
Value-based decision-making between affective and non-affective memories.
Pulcu E. et al, (2024), iScience, 27
Physical activity as a tool for preventing and treating depression: Lessons learned from the COVID‐19 pandemic
Raslescu A. et al, (2024), Mental Health Science
5-HT4 Receptor Agonist Effects on Functional Connectivity in the Human Brain: Implications for Procognitive Action.
de Cates AN. et al, (2023), Biol Psychiatry Cogn Neurosci Neuroimaging, 8, 1124 - 1134
The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression.
Smith ALW. et al, (2023), CNS Drugs
Serotonin releasing agent fenfluramine improves executive function in healthy volunteers: an experimental medicine study
Colwell M. et al, (2023), Neuroscience Applied, 2, 101086 - 101086
Positive and negative personality descriptors: UK dataset of self-referential valence, imageability and subjective frequency ratings of 300 adjectives for use in cognitive-emotional tasks
Raslescu A. et al, (2022), Data in Brief, 108831 - 108831
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
Colwell MJ. et al, (2022), Transl Psychiatry, 12
Acute neural effects of fluoxetine on emotional regulation in depressed adolescents.
Capitão LP. et al, (2022), Psychol Med, 53, 1 - 12
Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability.
Gillespie AL. et al, (2022), Biol Psychiatry
The Effect of the 5-HT4 Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain.
de Cates AN. et al, (2022), Front Psychiatry, 13
Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task.
de Cates AN. et al, (2021), Transl Psychiatry, 11
How representative are neuroimaging samples? Large-scale evidence for trait anxiety differences between fMRI and behaviour-only research participants.
Charpentier CJ. et al, (2021), Soc Cogn Affect Neurosci, 16, 1057 - 1070
The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.
Murphy SE. et al, (2021), Lancet Psychiatry, 8, 824 - 835